Literature DB >> 33717107

Monocyte Subset Recruitment Marker Profile Is Inversely Associated With Blood ApoA1 Levels.

Vyoma K Patel1,2, Helen Williams1,2, Stephen C H Li3,4, John P Fletcher1,2, Heather J Medbury1,2.   

Abstract

Dyslipidemia promotes development of the atherosclerotic plaques that characterise cardiovascular disease. Plaque progression requires the influx of monocytes into the vessel wall, but whether dyslipidemia is associated with an increased potential of monocytes to extravasate is largely unknown. Here (using flow cytometry) we examined recruitment marker expression on monocytes from generally healthy individuals who differed in lipid profile. Comparisons were made between monocyte subsets, participants and relative to participants' lipid levels. Monocyte subsets differed significantly in their expression of recruitment markers, with highest expression being on either the classical or non-classical subsets. However, these inter-subset differences were largely overshadowed by considerable inter-participant differences with some participants having higher levels of recruitment markers on all three monocyte subsets. Furthermore, when the expression of one recruitment marker was high, so too was that of most of the other markers, with substantial correlations evident between the markers. The inter-participant differences were explained by lipid levels. Most notably, there was a significant inverse correlation for most markers with ApoA1 levels. Our results indicate that dyslipidemia, in particular low levels of ApoA1, is associated with an increased potential of all monocyte subsets to extravasate, and to do so using a wider repertoire of recruitment markers than currently appreciated.
Copyright © 2021 Patel, Williams, Li, Fletcher and Medbury.

Entities:  

Keywords:  adhesion; atherosclerosis; cardiovascular disease; dyslipidemia; migration; monocytes

Mesh:

Substances:

Year:  2021        PMID: 33717107      PMCID: PMC7952433          DOI: 10.3389/fimmu.2021.616305

Source DB:  PubMed          Journal:  Front Immunol        ISSN: 1664-3224            Impact factor:   7.561


  57 in total

1.  Gene expression profiling reveals the defining features of the classical, intermediate, and nonclassical human monocyte subsets.

Authors:  Kok Loon Wong; June Jing-Yi Tai; Wing-Cheong Wong; Hao Han; Xiaohui Sem; Wei-Hseun Yeap; Philippe Kourilsky; Siew-Cheng Wong
Journal:  Blood       Date:  2011-06-07       Impact factor: 22.113

2.  Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease.

Authors:  Filip K Swirski; Mikael J Pittet; Moritz F Kircher; Elena Aikawa; Farouc A Jaffer; Peter Libby; Ralph Weissleder
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-26       Impact factor: 11.205

3.  Immunosuppression and monocyte subsets.

Authors:  Kyrill S Rogacev; Adam M Zawada; Johanna Hundsdorfer; Marina Achenbach; Gerhard Held; Danilo Fliser; Gunnar H Heine
Journal:  Nephrol Dial Transplant       Date:  2014-10-13       Impact factor: 5.992

4.  Phenotypic and functional heterogeneity of human intermediate monocytes based on HLA-DR expression.

Authors:  Eanna P Connaughton; Serika Naicker; Shirley A Hanley; Stephanie M Slevin; John K Eykelenboom; Noel F Lowndes; Timothy O'Brien; Rhodri Ceredig; Matthew D Griffin; Michael C Dennedy
Journal:  Immunol Cell Biol       Date:  2018-03-05       Impact factor: 5.126

5.  TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells.

Authors:  Jeong-Ki Min; Young-Myeong Kim; Sung Wan Kim; Min-Chul Kwon; Young-Yun Kong; In Koo Hwang; Moo Ho Won; Jaerang Rho; Young-Guen Kwon
Journal:  J Immunol       Date:  2005-07-01       Impact factor: 5.422

6.  Apolipoprotein A1 is a stronger prognostic marker than are HDL and LDL cholesterol for cardiovascular disease and mortality in elderly men.

Authors:  Gösta Florvall; Samar Basu; Anders Larsson
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2006-12       Impact factor: 6.053

7.  Combined inhibition of CCL2, CX3CR1, and CCR5 abrogates Ly6C(hi) and Ly6C(lo) monocytosis and almost abolishes atherosclerosis in hypercholesterolemic mice.

Authors:  Christophe Combadière; Stéphane Potteaux; Mathieu Rodero; Tabassome Simon; Adeline Pezard; Bruno Esposito; Régine Merval; Amanda Proudfoot; Alain Tedgui; Ziad Mallat
Journal:  Circulation       Date:  2008-03-17       Impact factor: 29.690

8.  High-density lipoprotein reduces the human monocyte inflammatory response.

Authors:  Andrew J Murphy; Kevin J Woollard; Anh Hoang; Nigora Mukhamedova; Roslynn A Stirzaker; Sally P A McCormick; Alan T Remaley; Dmitri Sviridov; Jaye Chin-Dusting
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-07-10       Impact factor: 8.311

9.  Distinct functions of chemokine receptor axes in the atherogenic mobilization and recruitment of classical monocytes.

Authors:  Oliver Soehnlein; Maik Drechsler; Yvonne Döring; Dirk Lievens; Helene Hartwig; Klaus Kemmerich; Almudena Ortega-Gómez; Manuela Mandl; Santosh Vijayan; Delia Projahn; Christoph D Garlichs; Rory R Koenen; Mihail Hristov; Esther Lutgens; Alma Zernecke; Christian Weber
Journal:  EMBO Mol Med       Date:  2013-02-18       Impact factor: 12.137

10.  Clinical significance of monocyte heterogeneity.

Authors:  Brian K Stansfield; David A Ingram
Journal:  Clin Transl Med       Date:  2015-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.